Latest filing published 08 Sept 2023 for Surface Oncology, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Henry C. Rath, listed as senior executive, appears in our data through filings on Surface Oncology, Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 1 March 2022 to 8 September 2023.
The open-market record consists of 1 sale worth €9,611, with no purchase. Besides market trades, the filings include 1 share grant.
Most recently, on 8 September 2023, the filings show a transaction in Surface Oncology, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations